Paulo V Steagall

Dr. Paulo V Steagall

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2014 in Journal of Small Animal Practice
Verified
Journal Article
Closed access
PDF file
KMKarol Mathews
Karol Mathews
PKPeter W Kronen
Peter W Kronen
DLDuncan Lascelles
Duncan Lascelles
ANAndrea Nolan
Andrea Nolan
SRSheilah Robertson
Sheilah Robertson
KYKazuto Yamashita
Kazuto Yamashita

13 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MEMarina C. Evangelista
Marina C. Evangelista
RWRyota Watanabe
Ryota Watanabe
VLVivian S. Y. Leung
Vivian S. Y. Leung
BMBeatriz Monteiro
Beatriz Monteiro
EOElizabeth O’tOole
Elizabeth O’tOole
PSPaulo V Steagall
Paulo V Steagall
Grimace scales have been used for pain assessment in different species. This study aimed to develop and validate the Feline Grimace Scale (FGS) to detect naturally-occurring acute pain. Thirty-five client-owned and twenty control cats were video-recorded undisturbed in their cages in a prospective, case-control study. Painful cats received analgesic treatment and videos were repeated one hour later. Five action units (AU) were identified: ear position, orbital tightening, muzzle tension, whiskers change and head position. Four observers independently scored (0–2 for each AU) 110 images of control and painful cats. The FGS scores were higher in painful than in control cats; a very strong correlation with another validated instrument for pain assessment in cats was observed (rho = 0.86, p < 0.001) as well as good overall inter-rater reliability [ICC = 0.89 (95% CI: 0.85–0.92)], excellent intra-rater reliability (ICC > 0.91), and excellent internal consistency (Cronbach’s alpha = 0.89). The FGS detected response to analgesic treatment (scores after analgesia were lower than before) and a cut-off score was determined (total pain score > 0.39 out of 1.0). The FGS is a valid and reliable tool for acute pain assessment in cats.

1 September 2013 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Closed access
PDF file
BMBeatriz Monteiro
Beatriz Monteiro
PSPaulo V Steagall
Paulo V Steagall
BLB. Duncan Lascelles
B. Duncan Lascelles

27 October 2022 in Journal of Small Animal Practice
Verified
Journal Article
Closed access
BMBeatriz Monteiro
Beatriz Monteiro
BLB. Duncan Lascelles
B. Duncan Lascelles
JMJ. Murrell
J. Murrell
SRS. Robertson
S. Robertson
PSPaulo V Steagall
Paulo V Steagall
BWB. Wright
B. Wright

1 March 2007 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
Stelio Pacca Loureiro LunaStelio Pacca Loureiro Luna
Stelio Pacca Loureiro Luna
ABAna C. Basílio
Ana C. Basílio
PSPaulo V Steagall
Paulo V Steagall
LMLuciana P. Machado
Luciana P. Machado
FMFlávia Q. Moutinho
Flávia Q. Moutinho
CBCláudia Valéria Seullner Brandão
Cláudia Valéria Seullner Brandão
Objective—To evaluate adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. Animals—36 adult dogs. Procedures—Values for CBC, urinalysis, serum biochemical urinalyses, and occult blood in feces were investigated before and 7, 30, 60, and 90 days after daily oral administration (n = 6 dogs/group) of lactose (1 mg/kg, control treatment), etodolac (15 mg/kg), meloxicam (0.1 mg/kg), carprofen (4 mg/kg), and ketoprofen (2 mg/kg for 4 days, followed by 1 mg/kg daily thereafter) or flunixin (1 mg/kg for 3 days, with 4-day intervals). Gastroscopy was performed before and after the end of treatment. Results—For serum γ-glutamyltransferase activity, values were significantly increased at day 30 in dogs treated with lactose, etodolac, and meloxicam within groups. Bleeding time was significantly increased in dogs treated with carprofen at 30 and 90 days, compared with baseline. At 7 days, bleeding time was significantly longer in dogs treated with meloxicam, ketoprofen, and flunixin, compared with control dogs. Clotting time increased significantly in all groups except those treated with etodolac. At day 90, clotting time was significantly shorter in flunixin-treated dogs, compared with lactose-treated dogs. Gastric lesions were detected in all dogs treated with etodolac, ketoprofen, and flunixin, and 1 of 6 treated with carprofen. Conclusions and Clinical Relevance—Carprofen induced the lowest frequency of gastrointestinal adverse effects, followed by meloxicam. Monitoring for adverse effects should be considered when nonsteroidal anti-inflammatory drugs are used to treat dogs with chronic pain.

21 May 2021 in Animals
Verified
Journal Article
Open access
PDF file
PSPaulo V Steagall
Paulo V Steagall
HBHedie Bustamante
Hedie Bustamante
CJCraig Johnson
Craig Johnson
PTPatricia Turner
Patricia Turner
Pain causes behavioral, autonomic, and neuroendocrine changes and is a common cause of animal welfare compromise in farm animals. Current societal and ethical concerns demand better agricultural practices and improved welfare for food animals. These guidelines focus on cattle, sheep, and pigs, and present the implications of pain in terms of animal welfare and ethical perspectives, and its challenges and misconceptions. We provide an overview of pain management including assessment and treatment applied to the most common husbandry procedures, and recommendations to improve animal welfare in these species. A cost-benefit analysis of pain mitigation is discussed for food animals as well as the use of pain scoring systems for pain assessment in these species. Several recommendations are provided related to husbandry practices that could mitigate pain and improve farm animal welfare. This includes pain assessment as one of the indicators of animal welfare, the use of artificial intelligence for automated methods and research, and the need for better/appropriate legislation, regulations, and recommendations for pain relief during routine and husbandry procedures.